![]() |
市场调查报告书
商品编码
1856998
全球肠道健康饮品及滋补品市场:预测至2032年-依产品类型、剂型、主要成分、通路、特性、应用及地区进行分析Gut Health Shots and Tonics Market Forecasts to 2032 - Global Analysis By Product Type, Form, Base Ingredient, Distribution Channel, Nature, Application and By Geography |
||||||
据 Stratistics MRC 称,全球肠道健康饮品和滋补品市场预计到 2025 年将达到 12.1 亿美元,到 2032 年将达到 20.6 亿美元,预测期内复合年增长率为 7.9%。
肠道健康营养液是浓缩液体补充剂,旨在透过增强肠道菌丛平衡、促进营养吸收和改善胃肠道功能来支持消化器官系统健康。这些配方通常含有益生菌、益生元、酵素、草药和发酵成分,旨在减少腹胀、改善排便规律并增强肠道屏障的完整性。这些产品设计便于快速服用,提供了一种针对性的消化器官系统护理方法,通常作为日常健康养生或功能性营养策略的一部分。其功效取决于成分的品质和个人健康需求。
消费者越来越倾向于寻找天然解决方案。
富含益生菌、益生元和植物萃取物的肠道健康饮品和滋补品正日益受到欢迎,成为合成营养补充剂的便捷替代品。人们对肠道菌丛健康的日益关注,促使消费者寻求能够支持消化、免疫和整体健康的天然机能饮料。洁净标示趋势以及消费者对植物性、低糖配方的偏好进一步推动了这一转变。随着消费者越来越重视预防性健康,这些产品正成为日常健康生活方式中不可或缺的一部分,从而推动市场稳定成长。
缺乏标准化的临床证据
儘管肠道健康饮品广受欢迎,但许多配方缺乏标准化的临床证据来证实其健康功效。这种科学检验的缺失会阻碍消费者信任,并限制行销的弹性。此外,机能饮料的法律规范因地区而异,为全球品牌带来合规挑战。益生菌功效、使用方法和标籤缺乏统一指南,进一步加剧了产品开发和国际扩张的困难。
与微生物组检测和人工智慧主导的健康计划相结合
肠道健康产品与微生物组检测和数位化健康平台的融合带来了变革性的机会。各大品牌正探索与生技公司合作,基于个人的微生物组特征提供个人化的肠道健康解决方案。人工智慧驱动的应用程式和订阅模式正在提升消费者的参与度和忠诚度,并实现量身定制的产品推荐。这一趋势与精准营养的广泛发展趋势不谋而合,精准营养的核心在于利用数据主导的洞察来指导营养选择和补充剂的使用。
未经证实的健康声明
肠道健康领域的快速扩张导致大量产品涌现,这些产品往往做出夸大其词、缺乏依据的宣传。这不仅可能招致监管机构的批评,还会损害消费者对正规产品的信任。社群媒体和网红平台上的假讯息扭曲了消费者的认知,使得以实证为基础的品牌难以脱颖而出。此外,医疗专业人员的质疑态度也会限制临床推荐并将其纳入正式的健康通讯协定。
新冠疫情初期扰乱了生产和分销网络,影响了产品供应。然而,疫情也提升了消费者对免疫力和消化器官系统健康的关注度,加速了机能饮料的需求。随着人们对电商和居家健康生活方式的依赖日益加深,肠道健康饮品和滋补品成为一种便捷的免疫力增强选择。疫情也推动了常温保存配方和直销模式的创新,再形成了市场竞争格局。
预计在预测期内,益生元滋补品细分市场将占据最大份额。
由于益生元滋补品具有广泛的吸引力,且能满足各种饮食偏好,预计在预测期内,益生元滋补品将占据最大的市场份额。这些配方无需冷藏即可支持肠道有益菌丛的生长,因此非常适合主流零售和线上通路销售。其多样化的口味和功能定位,涵盖消化器官系统支持、能量补充和皮肤健康等领域,正在帮助消费群。随着人们对益生元的认知不断提高,预计该细分市场将继续保持其领先地位。
预计在预测期内,康普茶细分市场将以最高的复合年增长率成长。
由于发酵和益生菌的双重益处,预计在预测期内,康普茶类产品将呈现最高的成长率。这些产品吸引了注重健康的消费者,他们追求天然排毒、改善消化和抗氧化功效。口味创新、低糖配方和混合配方(例如康普茶+适应原)正在推动其普及。此外,主流零售商和健康咖啡馆的供应量增加也促进了这一细分市场的成长。
预计北美将在预测期内占据最大的市场份额,这主要得益于其成熟的机能饮料产业、较高的消费者意识和强大的零售基础设施。该地区拥有众多先锋品牌,并率先接受了肠道健康理念。对研发、网红行销和洁净标示创新的策略性投资进一步巩固了该地区的领先地位。此外,人们对整体健康和预防性医疗保健日益增长的兴趣也持续推动着该品类的成长。
预计亚太地区在预测期内将实现最高的复合年增长率,这主要得益于健康意识的提高、都市化的加快以及可支配收入的增加。中国、印度和日本等国家对消化器官系统健康食品的需求激增,这得益于人们对发酵食品的传统认知。政府推行的肠道健康教育措施以及现代零售通路的扩张正在加速市场渗透。本土新兴企业和全球参与企业都在寻求透过提供符合当地文化的产品来把握这一充满活力的市场机会。
According to Stratistics MRC, the Global Gut Health Shots and Tonics Market is accounted for $1.21 billion in 2025 and is expected to reach $2.06 billion by 2032 growing at a CAGR of 7.9% during the forecast period. Gut health shots and tonics are concentrated liquid supplements formulated to support digestive wellness by enhancing microbiome balance, nutrient absorption, and gastrointestinal function. Typically infused with probiotics, prebiotics, enzymes, herbs, or fermented ingredients, these formulations aim to reduce bloating, improve regularity, and strengthen gut barrier integrity. Designed for quick consumption, they offer a targeted approach to digestive care, often used as part of daily wellness routines or functional nutrition strategies. Their efficacy depends on ingredient quality and individual health needs.
Consumers increasingly seek natural solutions
Gut health shots and tonics, often infused with probiotics, prebiotics, and botanical extracts, are gaining traction as convenient alternatives to synthetic supplements. The growing awareness of gut microbiome health is prompting consumers to seek natural, functional beverages that support digestion, immunity, and overall wellness. This shift is further supported by clean-label trends and a preference for plant-based, low-sugar formulations. As consumers prioritize preventive health, these products are becoming staples in daily wellness routines, driving consistent market growth.
Lack of standardized clinical evidence
Despite the popularity of gut health beverages, many formulations lack standardized clinical evidence to substantiate their health claims. This gap in scientific validation can hinder consumer trust and restrict marketing flexibility. Moreover, regulatory frameworks for functional beverages vary across regions, creating compliance challenges for global brands. The absence of harmonized guidelines for probiotic efficacy, dosage, and labeling further complicates product development and international expansion.
Integration with microbiome testing and AI-driven wellness plans
The convergence of gut health products with microbiome testing and digital wellness platforms presents a transformative opportunity. Brands are exploring partnerships with biotech firms to offer personalized gut health solutions based on individual microbiome profiles. AI-powered apps and subscription models are enabling tailored product recommendations, enhancing consumer engagement and loyalty. This trend aligns with the broader shift toward precision nutrition, where data-driven insights inform dietary choices and supplement use.
Unsubstantiated health claims
The rapid expansion of the gut health category has led to a surge in products making bold, often unsubstantiated claims. This not only risks regulatory backlash but also undermines consumer confidence in legitimate offerings. Misinformation on social media and influencer platforms can distort public perception, making it harder for evidence-based brands to differentiate themselves. Additionally, skepticism from healthcare professionals may limit clinical endorsement and integration into formal wellness protocols.
The COVID-19 pandemic initially disrupted manufacturing and distribution networks, affecting product availability. However, it also heightened consumer focus on immunity and digestive health, accelerating demand for functional beverages. With increased reliance on e-commerce and home-based wellness, gut health shots and tonics gained visibility as convenient, immune-supportive options. The pandemic also catalyzed innovation in shelf-stable formulations and direct-to-consumer delivery models, reshaping the competitive landscape.
The prebiotic tonics segment is expected to be the largest during the forecast period
The prebiotic tonics segment is expected to account for the largest market share during the forecast period due to their broad appeal and compatibility with various dietary preferences. These formulations support beneficial gut bacteria without requiring refrigeration, making them ideal for mainstream retail and online distribution. Their versatility in flavoring and functional positioning ranging from digestive support to energy and skin health has expanded their consumer base. As awareness of prebiotics grows, this segment is expected to maintain its leadership.
The kombucha-based segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the kombucha-based segment is predicted to witness the highest growth rate driven by their dual benefits of fermentation and probiotic content. These products appeal to health-conscious consumers seeking natural detoxification, improved digestion, and antioxidant support. Innovations in flavor profiles, sugar reduction, and hybrid formulations (e.g., kombucha + adaptogens) are fueling adoption. The segment is also benefiting from increased availability in mainstream retail and wellness-focused cafes.
During the forecast period, the North America region is expected to hold the largest market share due to its mature functional beverage industry, high consumer awareness, and strong retail infrastructure. The region is home to several pioneering brands and has witnessed early adoption of gut health trends. Strategic investments in R&D, influencer marketing, and clean-label innovation have further solidified its dominance. Additionally, rising interest in holistic wellness and preventive care continues to drive category growth.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by increasing health consciousness, urbanization, and disposable income. Countries like China, India, and Japan are witnessing a surge in demand for digestive health products, supported by traditional knowledge of fermented foods. Government initiatives promoting gut health education and the expansion of modern retail channels are accelerating market penetration. Local startups and global entrants alike are tapping into this dynamic landscape with culturally tailored offerings.
Key players in the market
Some of the key players in Gut Health Shots and Tonics Market include OLIPOP, Poppi, Health-Ade, Suja Life, Remedy Drinks, Culture Pop Soda, GT's Living Foods, Bio-K+ International, GoodBelly, Tropicana Brands Group, Humm Kombucha, Kevita, Symprove, Seed Health, Your Super, MOJU, and The Gut Stuff.
In September 2025, Seed Health New category includes multivitamin, energy, and sleep formulations targeting human and microbial pathways expands Seed's portfolio beyond probiotics into holistic microbiome support.
In September 2025, The Gut Stuff Danone's acquisition of Akkermansia Company signals broader gut health investment. The Gut Stuff remains active in education and community outreach.
In April 2025, Tropicana Brands Group launched "Fresh & Light" juice range, blended fruit juices with reduced sugar and calories to meet health-conscious demand. Part of broader innovation strategy post-PepsiCo divestment.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.